LNSR
LENSAR Inc

162
Mkt Cap
$119.92M
Volume
19,830.00
52W High
$17.31
52W Low
$7.00
PE Ratio
-2.29
LNSR Fundamentals
Price
$9.76
Prev Close
$10.04
Open
$10.16
50D MA
$11.81
Beta
0.66
Avg. Volume
44,829.13
EPS (Annual)
-$2.73
P/B
-4.63
Rev/Employee
$382,100.00
Loading...
Loading...
News
all
press releases
LENSAR (NASDAQ:LNSR) Releases Earnings Results, Misses Expectations By $0.23 EPS
LENSAR (NASDAQ:LNSR - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.23). The...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
LENSAR - Top Healthcare Equipment Stock
Summary LENSAR (LNSR) has shown strong technical buy signals, high Weighted Alpha, and consistent price appreciation, gaining 16.65% since the Trend Seeker buy signal on 2/28.. The company specializes in femtosecond laser systems for cataract treatment, with notable products like the LENSAR Laser System and ALLY Adaptive Cataract Treatment System.....
barchart.com·9mo ago
News Placeholder
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company) today announced that a majority of the independent members of LENSARs board of directors granted three newly-hired non-executive employees stock...
Business Wire·1y ago
News Placeholder
LENSAR to Participate in Two Upcoming Investor Conferences
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced that management will...
Business Wire·1y ago
News Placeholder
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced financial results for the...
Business Wire·1y ago
News Placeholder
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company) today announced that a majority of the independent members of LENSARs board of directors granted three newly-hired non-executive employees stock...
Business Wire·1y ago
News Placeholder
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company) today announced that a majority of the independent members of LENSARs board of directors granted three newly-hired non-executive employees stock...
Business Wire·1y ago
News Placeholder
LENSAR Reports First Quarter 2024 Results and Provides Business Update
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial...
Business Wire·2y ago
News Placeholder
LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the...
Business Wire·2y ago
News Placeholder
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company) today announced that a majority of the independent members of LENSARs board of directors granted two newly-hired non-executive employees stock...
Business Wire·2y ago

Latest LNSR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.